Regencell Bioscience Holdings L (NASDAQ:RGC)
| Market Cap | 3.80B-53.5% |
| Revenue (ttm) | 0 |
| Net Income | -11.70M-160.1% |
| EPS | -0.02-88.5% |
| Shares Out | 495.88M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Feb 15, 2018 |
| Volume | 473,685 |
| Open | 9.82 |
| Previous Close | 9.81 |
| Day's Range | 7.55 - 9.82 |
| 52-Week Range | 4.51 - 69.00 |
| Beta | 1.43 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About RGC
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
$RGC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in RGC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RGC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RGC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RGC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RGC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in RGC
| ETF | Est. Holding Size |
|---|---|
| GXCState Street SPDR S&P China ETF | $39.74K |
Estimated from each fund’s disclosed top holdings × AUM
RGC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from RGC’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.